The Relationship Between IL-6 and IL-10 Expression Levels and the Prognosis in B-Cell Non-Hodgkin Lymphoma Patients Treated with R-CHOP
The expression of IL-6 and IL-10 in the blood can serve as important biomarkers for predicting the prognosis of rituximab in patients with B-NHL.
Authors
- Wei Xiu
- Wenxin Lin (ORCID: https://orcid.org/0000-0002-8574-3270)
- Shan‐Chi Yu (ORCID: https://orcid.org/0000-0002-3642-2788)
- Mei Dong (ORCID: https://orcid.org/0000-0001-5673-3359)
- Wenli Shan (ORCID: https://orcid.org/0000-0002-1061-6963)
- Yuxin Qin
- Na Wang (ORCID: https://orcid.org/0000-0002-5806-4379)
- Duo Liu (ORCID: https://orcid.org/0000-0002-0674-0558)
- Chuiming Jia
- Quan Dong
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Heilongjiang Provincial Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jir.s532323
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Harbin Medical University
- National Natural Science Foundation of China
- Chinese Pharmaceutical Association